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1. Discussion
COVID-19 is a novel coronavirus first detected in Wuhan, China in
late 2019. Shortly after, it was detected in the United States by mid-
January 20201,3. The virus can cause severe respiratory tract infections
in its host more often in the elderly, immunocompromised, or in-
dividuals with multiple medical comorbidities3. Current data suggests
that while up to 80% of those infected are either asymptomatic or ex-
perience mild symptoms, 15% of those infected will have severe disease
requiring hospitalization, and 5% will require intensive care and me-
chanical ventilation2. Typical symptoms include fever (88.7%), dry
cough (67.8%), and fatigue, with symptoms such as sputum production,
sore throat, headache, and GI symptoms occurring less commonly2.
2. Visual case discussion
A 76 year old male patient presented with his wife for altered
mental status and lethargy. The patient's wife stated that for the last
three days the patient ``had not seemed himself''. She described some
confusion at home and decreased interaction. She reported the patient
had not had fevers at home or dry cough, however she had recently
experienced a dry cough. The couple spent the previous weekend at a
nearby casino after taking public transit. The patient and wife had no
recent long distance of international travel and no known sick contacts
or known exposure to COVID-19 + patients. The patient had no known
history of pulmonary disease.
When vital signs were obtained the patient was found to have an
oxygen saturation of 70% on room air. The patient was tachypneic to a
rate of 23 but did not appear to be in respiratory distress and was able
to answer questions in full sentences. Lung sounds were clear
bilaterally. The patient was moved to an isolation room and was placed
on 15 L O2 via non-rebreather mask.
The patient was then weaned and able to maintain oxygen satura-
tion of 93% on 5 L via nasal cannula. Cell counts and electrolytes were
within normal limits. The patient was negative for Flu A/B and had a
negative respiratory viral panel. Chest X-ray obtained showed non-
specific bibasilar airspace disease (Fig. 1). Of note, the patient's D-
dimer was elevated to 2574 and CT imaging was ordered to evaluate for
pulmonary embolism. CTA of the chest with PE protocol revealed bi-
basilar opacities. The patient was admitted to the progressive care unit
for respiratory support and COVID-19 rule out.
On follow-up, patient tested positive for COVID-19 with declining
respiratory status over the next 24 h. He was upgraded to the intensive
care unit for high flow nasal cannula at 25 L/min with FiO2 of 0.6.
Questions
1 What is the R° for COVID-19? How does this compare to the R° for
typical influenza?
a 0.5, less than typical flu
b 1.3, the same as typical flu
c 1.5–1.8, the same as pandemic flu
d 2.2, higher than pandemic flu
e 3.0, the same as pandemic SARS
2 What lab abnormalities can be expected in COVID-19+ patients?
a Lymphopenia
b Elevated pro-calcitonin
c Elevated D-dimer
d A and B
e A and C
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f B and C
g All of the above
Answers
1 Correct Answer= D, Explanation: The R0 is the expected number of
secondary cases produced by a single typical infection in a suscep-
tible population. Based on the most up-to-date statistics, COVID-19
is considered highly virulent with an expected R0 of at least 2.2
much higher than the R0 of seasonal flu, which is typically closer to
1.3.1
2 Correct Answer = E, Explanation: Patient typically present with
lymphopenia and mildly elevated AST and ALT. Procalcitonin is
normal. Patient who present with severe lymphopenia and elevated
D-dimer has an associated increased risk of mortality.1
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Fig. 1. Chest Radiograph (AP view): Upper lung emphysematous changes.
Nonspecific bibasal airspace disease which could represent atypical infection or
pulmonary edema superimposed on chronic inflammatory changes. Stable
mediastinal contour and heart size. No large effusion or pneumothorax.
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Since January 2020 Elsevier has created a COVID-19 resource centre with 
free information in English and Mandarin on the novel coronavirus COVID-
19. The COVID-19 resource centre is hosted on Elsevier Connect, the 
company's public news and information website. 
 
Elsevier hereby grants permission to make all its COVID-19-related 
research that is available on the COVID-19 resource centre - including this 
research content - immediately available in PubMed Central and other 
publicly funded repositories, such as the WHO COVID database with rights 
for unrestricted research re-use and analyses in any form or by any means 
with acknowledgement of the original source. These permissions are 
granted for free by Elsevier for as long as the COVID-19 resource centre 
remains active. 
 
